Shares of the cloud-computing company fall sharply as top executives, including the CEO and its largest shareholder, Magnetar Financial, sell millions in stock following a lockup expiration
CoreWeave stock has moved above the $100 mark after Cantor Fitzgerald initiated coverage with an Overweight rating and a $116 price target, pointing to the trillion-dollar AI infrastructure opportunity. Shares are now up 160% year-to-date.
: CRWV lifts 2025 revenue outlook again as data center expansion, strong demand and new contracts fuel rapid growth.
CoreWeave's revenue growth is explosive, but capex and debt outpace cash generation, raising financing and execution risks. The company has a massive $30B backlog and strong demand from top-tier AI/cloud customers, supporting long-term growth potential. Improving cost of capital and potential for high free cash flow margins could drive significant upside if execution is strong.
CoreWeave, Inc.'s explosive revenue growth is impressive, but heavy capital spending and rising debt raise concerns about the sustainability of its business model. The company's reliance on long-term contracts and a single supplier (Nvidia) makes it vulnerable to technological shifts and market changes. Recent M&A activity, expensive debt issuances, and slowing sequential growth have introduced significant volatility and uncertainty to the stock.
The quantitative-trading firm revealed a 5.4% stake of nearly 20 million shares in CoreWeave.
CRWV's IPO lock-up expiry and FQ2'25 bottom-line miss have triggered the much needed correction from June 2025 heights, as it finally nears our fair value estimates. Thanks to the clarity from the new customer wins, the growing multi-year backlog, and the intense capex, we believe that the management is likely to deliver the ambitious growth targets. For now, CRWV's lumpy profit margin performance and increased debt reliance are not causes for concern, since these are typical pains for most high-growth start-up companies.
CoreWeave, Inc. offers a rare early-stage hypergrowth opportunity, with explosive demand, a $30B backlog, and institutional adoption accelerating rapidly. The company's vertical integration strategy, highlighted by the proposed Core Scientific acquisition, will unlock scale, operational leverage, and cost savings. Despite a recent stock pullback, CoreWeave's current EV/EBITDA multiple is attractive given its nascent business model and massive growth runway.
CoreWeave's 2Q25 results are neutral. Given late-year capacity additions most revenue growth is deferred to 2026. My updated revenue forecast stands at $5.2B for 2025, $13.5B for 2026, and $18.1B for 2027, down from prior estimates of $6.3B, $16.3B, and $22.6B respectively. CoreWeave will require ~$17.1B in funding by year-end to support its accelerated buildout, leaving a financing gap of ~$11.5B even after recent debt raises.
CoreWeave stock has plunged over 50% from its June peak, highlighting the inherent risks of chasing speculative AI-driven growth stories. Despite a strong Q2 posting >80% YoY backlog spurt and surpassing $1B in revenue, heavy selling persisted. CoreWeave remains free cash flow unprofitable, with heavy customer concentration and uncertain prospects of diversifying quickly beyond Microsoft and OpenAI.
CRWV has raised $25 billion through debt and equity to fuel data center investments, but soaring interest costs test its profitability.
CoreWeave's (CRWV 0.49%) stock has been on a roll since it debuted earlier this year, but shares of the artificial intelligence (AI) infrastructure provider plunged after it reported its Q2 results. The company originally priced its March IPO at $40 and didn't get a big initial pop, actually closing its first day of trading at breakeven.